IR情報

2020/08/06~2021/01/04

IR情報&株価推移

日付始値高値安値終値前日比出来高時価総額25日乖離
2021
01/041,0051,008988997-1.97%49,000566億4365万-3.3%
2020
12/301,0341,0341,0091,017-1.26%53,000577億7993万-1.36%
12/299991,0319991,030+3.31%72,400585億1851万-0.1%
12/281,0081,012987997-0.89%67,700566億4365万-3.2%
12/251,0101,0211,0031,006-0.2%38,400571億5497万-2.33%
12/249901,0159891,008+0.8%80,900572億6860万-2.04%
12/231,0101,0109951,000-0.1%46,500568億1409万-2.82%
12/2215:00 人事異動に関するお知らせ
12/221,0221,0249981,001-3.1%66,800568億7090万-2.82%
12/211,0341,0481,0211,033-0.96%35,300586億8895万+0.29%
12/181,0291,0431,0241,043+2.05%70,500592億5709万+1.36%
12/171,0301,0371,0171,022-0.58%52,700580億6400万-0.68%
12/161,0461,0521,0261,028-1.91%61,800584億488万-0.29%
12/151,0401,0541,0401,048+0.38%52,800595億4116万+1.55%
12/141,0421,0601,0391,044-0.67%61,600593億1391万+1.16%
12/111,0421,0571,0331,051+1.25%58,200597億1161万+1.94%
12/101,0471,0561,0381,038-1.42%48,300589億7302万+0.78%
12/091,0301,0531,0261,053+3.24%53,000598億2523万+2.43%
12/081,0491,0491,0201,020-1.83%66,700579億5037万-0.39%
12/071,0591,0731,0361,039-5.8%129,600590億2984万+1.66%
12/041,0921,1101,0881,103+1.01%95,300626億6594万+8.24%
12/031,0441,1091,0391,092+4.8%178,900620億4098万+7.69%
12/021,0571,0781,0331,042+0.48%145,900592億28万+3.27%
12/011,0001,0491,0001,037+4.43%115,700589億1621万+2.98%
11/301,0401,043993993-3.97%112,500564億1639万-1.1%
11/271,0201,0441,0141,034+2.78%106,200587億4577万+2.99%
11/261,0041,0261,0001,006+0.2%68,400571億5497万+0.4%
11/251,0201,0331,0041,004-0.79%63,500570億4134万+0.4%
11/241,0101,0351,0041,012+2.74%92,800574億9586万+1.2%
11/20988993978985-0.91%53,200559億6188万-1.4%
11/199911,005990994-0.3%53,400564億7320万-0.6%
11/181,0141,014995997-2.35%63,000566億4365万-0.4%
11/171,0231,0271,0011,021+0.59%57,300580億718万+1.79%
11/161,0201,0301,0111,015+0.4%74,900576億6630万+1.1%
11/131,0321,0321,0051,011-2.51%47,800574億3904万+0.5%
11/121,0201,0451,0201,037-3.45%74,300589億1621万+2.98%
11/1116:00 2021年3月期第2四半期決算短信〔日本基準〕(連結)
11/111,0661,0741,0471,074+1.99%80,100610億1833万+6.55%
11/101,0491,0581,0301,053+1.54%91,900598億2523万+4.36%
11/091,0441,0441,0271,037+0.58%59,000589億1621万+2.67%
11/061,0201,0431,0111,031+0.39%58,000585億7532万+1.98%
11/059851,0289721,027+5.01%128,200583億4807万+1.28%
11/04977990967978+1.03%89,600555億6418万-4.02%
11/02962985962968+1.04%65,800549億9604万-5.56%
10/30965970951958-1.14%45,600544億2790万-6.99%
10/29959981956969-0.1%53,900550億5285万-6.65%
10/28971976960970-1.02%54,000551億967万-7.27%
10/27978985971980-0.31%53,400556億7781万-7.02%
10/26975988963983+1.03%76,000558億4825万-7.35%
10/239709839649730%44,200552億8011万-8.98%
10/22990990970973-1.32%42,300552億8011万-9.57%
10/219751,001975986+1.13%41,000560億1869万-9.04%
10/209901,007975975-2.6%50,500553億9374万-10.63%
10/199941,0149911,001+1.52%43,700568億7090万-8.75%
10/169901,007986986-1.4%57,900560億1869万-10.45%
10/151,0141,0151,0001,000-2.06%48,900568億1409万-9.5%
10/141,0351,0431,0171,021-1.45%37,800580億718万-7.85%
10/131,0401,0501,0351,036-1.33%41,700588億5940万-6.67%
10/121,0571,0631,0451,050-1.04%19,400596億5479万-5.49%
10/091,0561,0641,0451,061+0.19%61,500602億7975万-4.59%
10/081,0551,0731,0551,059-0.19%52,300601億6612万-4.85%
10/071,0721,0761,0581,061-1.67%52,100602億7975万-4.76%
10/061,0881,0901,0731,079-0.83%44,100613億240万-3.14%
10/051,0811,1091,0811,088+1.49%49,000618億1373万-2.25%
10/021,1001,1131,0651,072-2.99%99,500609億470万-3.6%
09/3012:30 変形性関節症治療剤SI-613の韓国における販売提携に関する契約締結のお知らせ
09/301,1231,1701,1031,105-2.39%92,100627億7957万-0.54%
09/291,1311,1441,1121,132-0.35%69,900643億1355万+2.07%
09/281,0981,1411,0921,136+4.41%164,000645億4080万+2.81%
09/251,1661,1691,0881,088-6.85%254,000618億1373万-1.18%
09/2418:00 連結業績予想及び配当予想に関するお知らせ
09/241,1591,1811,1591,168+0.17%69,100663億5886万+6.28%
09/231,1511,1761,1411,166-0.6%68,400662億4523万+6.68%
09/181,1601,1901,1601,173+1.3%79,200666億4293万+7.71%
09/171,1691,1851,1501,158-1.19%52,000657億9071万+6.83%
09/161,1541,1751,1351,172+1.56%59,100665億8611万+8.52%
09/151,1631,1661,1461,154-1.28%44,300655億6346万+7.25%
09/141,1721,1941,1601,169+0.78%75,600664億1567万+9.05%
09/111,1601,1671,1431,160+2.56%93,000659億434万+8.82%
09/101,0991,1431,0981,131+3.19%93,900642億5673万+6.6%
09/091,0771,0981,0681,096-0.45%67,000622億6824万+3.79%
09/081,0631,1011,0631,101+3.57%50,000625億5231万+4.46%
09/071,0601,0771,0581,063+0.28%46,600603億9338万+0.95%
09/041,0531,0681,0461,060-1.03%48,500602億2293万+0.95%
09/031,0981,0981,0701,071-0.46%29,100608億4789万+1.9%
09/021,0911,0911,0611,076-0.74%32,300611億3196万+2.48%
09/011,0861,0951,0711,084-0.09%57,400615億8647万+3.24%
08/311,0951,1171,0781,085+1.5%78,500616億4329万+3.24%
08/281,0651,1171,0511,069+1.52%176,300607億3426万+1.81%
08/2711:00 Dalton Chemical Laboratories, Inc.におけるVIDO-InterVacとの新型コロナウイルス感染症(COVID-19)ワクチン開発の提携に関するお知らせ
08/271,0541,2451,0291,053-0.47%631,600598億2523万+0.29%
08/261,0401,0611,0301,058+1.24%37,300601億931万+0.67%
08/251,0461,0631,0351,045-0.29%49,800593億7072万-0.57%
08/241,0311,0481,0291,048+1.65%42,600595億4116万-0.38%
08/211,0501,0531,0221,031-1.34%30,000585億7532万-2.09%
08/201,0291,0461,0251,045+1.36%31,400593億7072万-0.95%
08/191,0341,0401,0251,031-0.29%21,200585億7532万-2.46%
08/181,0421,0561,0281,034-1.24%52,600587億4577万-2.08%
08/171,0541,0541,0341,047-0.66%23,200594億8435万-1.04%
08/141,0681,0701,0531,054-1.5%30,700598億8205万-0.47%
08/131,0771,0771,0561,070-0.47%48,700607億9107万+0.75%
08/121,0491,0751,0481,075+2.38%53,000610億7514万+1.03%
08/111,0131,0541,0111,050+4.06%55,900596億5479万-1.5%
08/071,0301,0361,0031,009-1.94%44,400573億2541万-5.52%
08/061,0191,0401,0111,029+0.49%52,100584億6170万-3.92%
07/3115:00 2021年3月期第1四半期決算短信〔日本基準〕(連結)